Archive · 14 Jan 2026
Gabify's AI Tool Aids Early Autism Detection
Gabify is a company that uses AI to help detect autism and speech problems in children early.
It was started by people who have autism themselves, so they understand what families need.
The tool is called Neurolens, and it works by having parents record their child's speech and behavior on their phone.
The AI then analyzes these recordings to look for signs of autism or speech delays.
This helps families get the support their children need much faster than traditional methods.
Gabify is working to make this tool available to as many families as possible, especially in places where access to healthcare is limited.
They hope to help one million people by 2028.
Gabify's AI tool, Neurolens, helps detect autism and speech-language disorders in children within five minutes.
The platform is built by autistic innovators, ensuring a deep understanding of neurodiversity.
Screenings start at Rs 499, with subsidized access for underserved communities.
Gabify has completed over 2,500 screenings and is used by 75 therapists, clinics, and institutions.
The tool aims to save time and provide early intervention, with a goal to impact one million people by 2028.
- Who
- Gabify, an AI-enabled screening platform, and its team of autistic innovators
- What
- Developed an AI tool for early detection of autism and speech-language disorders
- When
- Product development began in 2024
- Where
- Headquartered in New Delhi, India, with operations across India and beyond
- Why
- To make early detection more accessible, affordable, and inclusive for families
- Company
- Gabify
- Headquarters
- New Delhi, India
- Founder
- Sahil Chopra
- Co-founders
- Prachi Chopra, Vasyl Leshchuk, Seymour Verdi, Kanak Kadulkar, Aniket Gupta
- Screening Cost
- Starting at Rs 499
- Screenings Completed
- Over 2,500 in four months
- Accuracy
- 90% accurate in assessments
- Goal
- Impact one million people by 2028